Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/EBIT(x) 41.6621.0223.3426.586.40

What is the latest EV/EBIT ratio of SUVEN PHARMACEUTICALS ?

The latest EV/EBIT ratio of SUVEN PHARMACEUTICALS is 41.66 based on Mar2024 Consolidated results.
Year EV/EBIT
Mar202441.66
Mar202321.02
Mar202223.34
Mar202126.58
Mar20206.40

How is EV/EBIT of SUVEN PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2024 41.66
98.19
Mar2023 21.02
-9.94
Mar2022 23.34
-12.19
Mar2021 26.58
315.31
Mar2020 6.4 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EV/EBIT ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹41,259.6 Cr 1.8% 2.5% 67.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹409,818.0 Cr -3.3% 3.4% 13.9% Stock Analytics
DIVIS LABORATORIES ₹164,628.0 Cr 4.1% 15.2% 60.2% Stock Analytics
CIPLA ₹120,775.0 Cr 0.6% 5.6% 11.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,758.0 Cr 1.9% 3.7% 28.2% Stock Analytics
DR REDDYS LABORATORIES ₹101,791.0 Cr 6.2% 11.4% 2.6% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

1.8%

2.5%

67.8%

SENSEX

0.7%

9.6%

10.7%


You may also like the below Video Courses